R Richard Hamer

This inventor holds 22 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Hoechst Marion Roussel, Hoechst Roussel Pharmaceuticals. Active years: 1985-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: R Richard Hamer. Retrieved from https://idiyas.com/inventor/r-richard-hamer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 178(Granted Patents)

Location History:

Budd Lake, NJ (US) (1985 - 1986)
Westfield, NJ (US) (1988 - 1990)
Far Hills, NJ (US) (1988 - 1997)
Lebanon, NJ (US) (1991 - 1999)

Company Filing History:

11 out of 236

Hoechst Marion Roussel

patents

11 out of 539

Hoechst Roussel Pharmaceuticals

patents

Years Active: 1985-1999

Loading Chart...

Areas of Expertise:

Aminoalkyloximes

Memory Enhancement

Analgesic Compounds

Pharmaceutical Compositions

Triazepines

Dibenzoxepinalkylamines

Alkylamino Compounds

Isoquinolinecarboxamides

Depression Treatment

Affective Disorders

Hexahydro Compounds

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5917057 - N-hydroxy-dibenz�b,e!oxepinalkylamines, (1999-06-29),

2. 5840749 - N-hydroxy-dibenz �b,e!oxepinalkylamines, N-hydroxy-dibenz (1998-11-24),

3. 5770740 - Aminoalkyloximers (1998-06-23),

4. 5696142 - Aminoalkyloximes (1997-12-09),

5. 5686483 - Aminoalkyloximes (1997-11-11),

6. 5686447 - Aminoalkyloximes for treating depression and affective disorders (1997-11-11),

7. 5686446 - Aminoalkyloximes (1997-11-11),

8. 5684021 - Aminoalkyloximes for treating depression and affective disorders (1997-11-04),

9. 5665756 - Aminoalkyloximes useful in the treatment of depression and obsessive (1997-09-09),

10. 5648367 - Aminoalkyloximes (1997-07-15),

11. 5639892 - Memory enhancing and analgesic 1,2,3,3a,8,8a,-hexahydro-3a,8(and (1997-06-17),

12. 5550254 - Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and (1996-08-27),

13. 5550253 - Memory enhancing and analgestic 1,2,3,3A,8,8A-hexahydro-3A,8(and (1996-08-27),

14. 5300527 - Alkylamino-and alkylamino alkyl diarylketones (1994-04-05),

15. 5177111 - Alkylamino- and alkylamino alkyl diarylketones and pharmaceutical (1993-01-05),

Title: The Innovative Mind of R Richard Hamer - A Pioneer in Pharmaceutical Treatments

Introduction:

R Richard Hamer, a visionary inventor based in Lebanon, NJ, US, has left an indelible mark on the field of pharmaceuticals with his groundbreaking inventions. With an impressive 22 patents to his name, Hamer's contributions to the medical world are profound and far-reaching.

Latest Patents:

One of Hamer's latest patents focuses on N-hydroxy-dibenz�b,e!oxepinalkylamines, N-hydroxy-dibenz�b,e!oxepinalkanoic acid amides, and related heterocyclic analogues. These compounds have shown promising results as analgesics and topical anti-inflammatory agents, offering potential treatments for various dermatoses and conditions involving cyclooxygenase and lipoxygenase metabolites.

Career Highlights:

R Richard Hamer has honed his expertise through esteemed positions at pharmaceutical giants like Hoechst Roussel Pharmaceuticals and Hoechst Marion Roussel. His tenure in these renowned companies provided him with a robust foundation for his inventive pursuits and a platform to drive innovation in pharmaceutical research.

Collaborations:

Throughout his illustrious career, Hamer has collaborated with esteemed colleagues like Brian S Freed and Gregory M Shutske. These partnerships have led to synergistic efforts in advancing pharmaceutical treatments and enhancing patient care through novel inventions and therapies.

Conclusion:

In conclusion, R Richard Hamer stands out as a trailblazing inventor whose relentless pursuit of innovation has revolutionized the pharmaceutical landscape. His patents serve as testaments to his ingenuity and commitment to improving healthcare outcomes, making him a true pioneer in the realm of pharmaceutical inventions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]